pseudouridine has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabanes-Mariscal, MA; Gómez de Terreros, J; Gutiérrez-Ortega, C; Medina Font, J; Montenegro Álvarez de Tejera, P; Villa-Corbatón, MC | 1 |
| Broekhuizen, R; Creutzberg, EC; Grimble, RF; Howell, WM; Schols, AM; Shale, DJ; Wouters, EF | 1 |
| Bolton, CE; Broekhuizen, R; Ionescu, AA; Nixon, LS; Schols, AM; Shale, DJ; Wouters, EF | 1 |
3 other study(ies) available for pseudouridine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
[Muscle catabolism in patients with chronic obstructive pulmonary disease].
Topics: Aged; Aged, 80 and over; Biomarkers; Bronchitis, Chronic; Chromatography, High Pressure Liquid; Creatinine; Cross-Sectional Studies; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Muscles; Pseudouridine; Pulmonary Disease, Chronic Obstructive | 2011 |
Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism.
Topics: Adipose Tissue; Body Composition; Body Mass Index; C-Reactive Protein; Cachexia; Case-Control Studies; Cross-Sectional Studies; Electric Impedance; Energy Metabolism; Female; Genetic Predisposition to Disease; Humans; Interleukin-1; Interleukin-6; Leptin; Male; Middle Aged; Polymorphism, Single Nucleotide; Pseudouridine; Pulmonary Disease, Chronic Obstructive; Tumor Necrosis Factor-alpha | 2005 |
Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD.
Topics: Biomarkers; Body Composition; Body Mass Index; Exercise Test; Female; Forced Expiratory Volume; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Muscle Strength; Muscle, Skeletal; Proteins; Pseudouridine; Pulmonary Disease, Chronic Obstructive; Tumor Necrosis Factor-alpha | 2007 |